Home/Filings/4/0001493152-21-022862
4//SEC Filing

Gray Robert 4

Accession 0001493152-21-022862

CIK 0001661053other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 9:50 PM ET

Size

7.0 KB

Accession

0001493152-21-022862

Insider Transaction Report

Form 4
Period: 2021-09-13
Gray Robert
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2021-09-13+1,0426,614 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-09-131,0422,084 total
    Common Stock (1,042 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") converts into one share of common stock of Hancock Jaffe Laboratories, Inc.
  • [F2]On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on September 26, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021.

Documents

1 file

Issuer

Hancock Jaffe Laboratories, Inc.

CIK 0001661053

Entity typeother

Related Parties

1
  • filerCIK 0001788480

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 9:50 PM ET
Size
7.0 KB